Price $2.89 |
Market Cap
131M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.22
|
P/S
9.32
|
Dividend %
-
|
|
P/CF
50.4
|
P/FCF
-
|
Op. Cash Flow
-25.6K
|
FCF
-0.7
|
|
Op. Margin
-251.40%
|
Net Margin
-248.40%
|
ROE
-87.60%
|
ROI
-33.70%
|
|
ROA
-66.80%
|
EPS Growth
-39.20%
|
Current Ratio
2.4
|
Debt/Equity
6.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Integer Holdings Corp (ITGR) | $85.41 | - | - | 2.79B | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.75 | - | - | 137.7M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $16.99 | - | - | 617.5M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.25 | - | - | 13.4M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $15.98 | - | - | 957.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
